次新異動 | 中國中免漲超6%創上市新高,獲高盛看高至196港元
今天是中國中免(1880.HK)上市第三個交易日,盤中股價持續走強且漲幅不斷擴大,截至發稿,盤中最高漲至175港元,漲幅6.4%,創上市新高。自上市以來累計漲幅爲10.8%。
高盛發表最新研報,首予中國中免H股“買入”評級,指集團是中國領先的免稅營運商,雖然隨着內地發放更多免稅經營許可證,市場競爭增加,但相信在當局專注於將中國海外支出匯回境內的方針下,公司仍處有利地位,給予其196港元的目標價。
另外,華西證券此前首予中國中免H股“買入”評級,目標價216.71港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.